Element Biosciences
PrivateLast Round
Series E
Jun 9, 2026
Est. Valuation
$1.03B
Total Funding Raised
$888.41M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Element Biosciences is a biotechnology company that develops modular and high-performing DNA sequencing platforms designed to enhance research and diagnostics by providing quality data and workflow flexibility.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery, Computing Hardware
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Element Biosciences Comparables
Compare Element Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ultima Genomics | 87% | |
| Singular Genomics | 84% | |
| Axbio | 81% |
Element Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jun 9, 2026 | ||||
| Series D | Jul 11, 2024 | ||||
| Series C | Jun 29, 2021 | ||||
| Series B Extension | Jun 26, 2020 | ||||
| Series B | Jan 9, 2020 | ||||
Series A | Jun 18, 2019 |
Key People
Founding team and executive leadership
Element Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series C |
| RA Capital Management | Series B Extension, Series B, Series C |
| Fusion Fund | Series D |
| Fidelity Management & Research Company | Series D, Series C, Series B |
| Fidelity Investments | Series D |
| Morgan Stanley | Series C |
| Logos Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 33% MoM, reaching 26K.
- Jun 9, 2026
$175M round led by Samsung Electronics
Element Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Element Biosciences's valuation, stock price, and market status.
Is Element Biosciences a public or private company?
Element Biosciences is a private company.
What is the current stock price of Element Biosciences?
Element Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Element Biosciences worth (valuation)?
Element Biosciences's valuation is estimated at $1.0B based on funding round data.
Can I buy Element Biosciences stock?
Element Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Element Biosciences's last funding round?
Element Biosciences's most recent funding round was Series E on July 11, 2024.
Who are the main investors in Element Biosciences?
Key investors in Element Biosciences include Fidelity Management & Research Company, Counterpoint Global (Morgan Stanley), Foresite Capital, T. Rowe Price, JSCapital.
Will Element Biosciences IPO soon?
No public IPO plans have been announced for Element Biosciences.
How can I track Element Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Element Biosciences's secondary market activity and sign up for updates.